1. Home
  2. EWTX vs STC Comparison

EWTX vs STC Comparison

Compare EWTX & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$28.57

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Stewart Information Services Corporation

STC

Stewart Information Services Corporation

HOLD

Current Price

$69.23

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EWTX
STC
Founded
2017
1893
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
EWTX
STC
Price
$28.57
$69.23
Analyst Decision
Buy
Buy
Analyst Count
7
3
Target Price
$34.71
$81.00
AVG Volume (30 Days)
1.1M
277.7K
Earning Date
03-02-2026
02-04-2026
Dividend Yield
N/A
3.10%
EPS Growth
N/A
69.60
EPS
N/A
3.60
Revenue
N/A
$2,796,513,000.00
Revenue This Year
N/A
$17.75
Revenue Next Year
N/A
$13.92
P/E Ratio
N/A
$18.84
Revenue Growth
N/A
16.09
52 Week Low
$10.60
$56.39
52 Week High
$30.48
$78.61

Technical Indicators

Market Signals
Indicator
EWTX
STC
Relative Strength Index (RSI) 56.47 52.53
Support Level $27.07 $67.29
Resistance Level $29.98 $68.38
Average True Range (ATR) 1.54 1.60
MACD -0.06 0.42
Stochastic Oscillator 61.43 82.86

Price Performance

Historical Comparison
EWTX
STC

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

Share on Social Networks: